The U.S. Food and Drug Administration (FDA) has approved the Samsung's GC85A Digital Radiography (DR) system.
The GC85A is the latest expansion of Samsung's growing DR portfolio, which also includes the mobile digital GM60A, the U-arm digital GU60A, and the ceiling digital GC80.
According to the company, the DR systems of the company combine advanced imaging technology, and user-friendly automated workflows to meet the demands of 21st century radiology departments.
The Samsung GC85A is a ceiling digital X-ray system that offers streamlined workflows, diagnostic confidence and improved total cost of ownership.
The new system's S-Vue imaging engine provides dependable and accurate diagnoses in various conditions with reliably clear images, enhanced sharpness and clarity.
Another feature is wireless, lightweight s-detector with high detective quantum efficiency and a portable grid that displays the patient's body structure clearly without increasing dose.
Other features include smart control to precisely position the entire system with one touch of the control panel's buttons, s-align for precise alignment for exceptional imaging and smart stitching that eliminates the need for the patient to stand for long periods of consecutive shooting.
"The Samsung GC85A represents NeuroLogica's latest commitment to introducing user- and patient-centric innovation to healthcare to provide fast, easy and accurate diagnoses. The system's superior image quality and ease of control will enable users to experience a new level of efficiency with a DR system designed for streamlined operation," said David Webster, Vice President of Global Sales & Chief Marketing Officer at NeuroLogica.